Premium
Treatment of post‐transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti‐IL6R humanised monoclonal antibody Tocilizumab
Author(s) -
Sivapalaratnam Suthesh,
Linpower Lisa,
Sirigireddy Bala,
Agapidou Alexandra,
Jain Susan,
Win Nay,
Tsitsikas Dimitris A.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16103
Subject(s) - medicine , haemolysis , tocilizumab , macrophage activation syndrome , immunology , arthritis , rheumatoid arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom